Proteome-scale characterisation of motif-based interactome rewiring by disease mutations
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Whole genome and exome sequencing are reporting on hundreds of thousands of missense mutations. Taking a pan-disease approach, we explored how mutations in intrinsically disordered regions (IDRs) break or generate protein interactions mediated by short linear motifs. We created a peptide-phage display library tiling ~57,000 peptides from the IDRs of the human proteome overlapping 12,301 single nucleotide variants associated with diverse phenotypes including cancer, metabolic diseases and neurological diseases. By screening 80 human proteins, we identified 366 mutation-modulated interactions, with half of the mutations diminishing binding, and half enhancing binding or creating novel interaction interfaces. The effects of the mutations were confirmed by affinity measurements. In cellular assays, the effects of motif-disruptive mutations were validated, including loss of a nuclear localisation signal in the cell division control protein CDC45 by a mutation associated with Meier-Gorlin syndrome. The study provides insights into how disease-associated mutations may perturb and rewire the motif-based interactome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1000 · Cited by 9,726 · cited 2×
“Most, if not all, mutant proteins for which we found perturbed interactions have more than one interactor based on the information provided in public databases (Del Toro et al, 2022, Szklarczyk et al, 2023).”
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
A reference map of the human binary protein interactome
Luck, K., Kim, D.-K., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., Brignall, R., Cafarelli, T., Campos-Laborie, F. J., Charloteaux, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2188-x · Cited by 1,197 · cited 1×
“Our PPI datasets include experimentally validated protein – protein interactions obtained from the IntAct (DelToro et al, 2022), HIPPIE (Alanis ‐ Lobato et al, 2017), HURI (Luck et al, 2020), Bioplex (Huttlin et al, 2021) and STRING (Szklarczyk et al, 2023) databases.”
The Cancer Genome Atlas: Creating Lasting Value beyond Its Data
Hutter, C., & Zenklusen, J. C. (2018) · Cell · doi:10.1016/j.cell.2018.03.042 · Cited by 871
Widespread macromolecular interaction perturbations in human genetic disorders
Sahni, N., Yi, S., Taipale, M., Fuxman Bass, J. I., Coulombe-Huntington, J., Yang, F., Peng, J., Weile, J., Karras, G. I., Wang, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.013 · Cited by 594 · cited 3×
“Furthermore, ~30% of disease mutations were reported to have edgetic effects, perturbing some but not all interactions of a given protein (Sahni et al, 2015).”
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527 · cited 1×
“Loss of the interaction on account of mutation of the KEAP1-binding TGE motif in NFE2L2 leads to increased abundance of NFE2L2 and results in the resistance of cancer cells to reactive oxygen species (Taguchi and Yamamoto, 2017).”
The IntAct database: efficient access to fine-grained molecular interaction data
del Toro, N., Shrivastava, A., Ragueneau, E., Meldal, B., Combe, C., Barrera, E., Perfetto, L., How, K., Ratan, P., Shirodkar, G., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1006 · Cited by 405
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Rubino, E., Rainero, I., Chiò, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25df · Cited by 286
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
Simonetta, K. R., Taygerly, J., Boyle, K., Basham, S. E., Padovani, C., Lou, Y., Cummins, T. J., Yung, S. L., von Soly, S. K., Kayser, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09358-9 · Cited by 217 · cited 1×
“This includes, for example, proteolysis-targeting chimeras (PROTACs) (Bekes et al, 2022) but also the stabilisation of SLiM-based interactions by small molecules, as shown for the S37A mutant CTNNB1 and β -TrCP E3 ligase interaction (Simonetta et al, 2019).”
Interactions by disorder – A matter of context
Bugge, K., Brakti, I., Fernandes, C. B., Dreier, J. E., Lundsgaard, J. E., Olsen, J. G., Skriver, K., & Kragelund, B. B. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00110 · Cited by 155 · cited 1×
“…likely to result in the reduction or enhancement of af fi nity, there is a growing literature reporting on the contribution of non-consensus residues in motif instances (wild-card positions) and of motif-fl anking regions to the af fi nity of interactions (Karlsson et al, 2022; Bugge et al, 2020).”
Cited by
Badonyi, M., & Marsh, J. A. (2025) · Nature Communications · doi:10.1038/s41467-025-63234-3 · Cited by 19
“Although pathogenic missense mutations are highly enriched in structured regions 96 , this limitation excludes certainvariants,e.g.,thoseinshortlinearmotifs 97 .”
Chen, Z., Chi, G., Balo, T., Chen, X., Montes, B. R., Clifford, S. C., D’Angiolella, V., Szabo, T., Kiss, A., Novak, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58350-z · Cited by 10
The fitness cost of spurious phosphorylation
Bradley, D., Hogrebe, A., Dandage, R., Dubé, A. K., Leutert, M., Dionne, U., Chang, A., Villén, J., & Landry, C. R. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00200-7 · Cited by 10
Pathogenic variations illuminate functional constraints in intrinsically disordered proteins
(2026) · doi:10.1016/j.isci.2026.115215 · Cited by 2
Metadata
- Authors
- Kliche, J., Simonetti, L., Krystkowiak, I., Kuss, H., Diallo, M., Rask, E., Nilsson, J., Davey, N. E., & Ivarsson, Y.
- Venue
- Molecular Systems Biology
- Published
- 2024-07-15
- Volume
- 20
- Issue
- 9
- Pages
- 1025-1048
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W4400652886
- Cited by
- 20
- References
- 13
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteome-scale characterisation of motif-based interactome rewiring by disease mutations. https://app.cochat.ai/papers/10.1038/s44320-024-00055-4
- The paper
- Kliche, J., Simonetti, L., Krystkowiak, I., Kuss, H., Diallo, M., Rask, E., Nilsson, J., Davey, N. E., & Ivarsson, Y. (2024). Proteome-scale characterisation of motif-based interactome rewiring by disease mutations. Molecular Systems Biology. https://doi.org/10.1038/s44320-024-00055-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.